Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/09/2000 | US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
05/09/2000 | US6060596 Encoded combinatorial chemical libraries |
05/09/2000 | US6060588 Bap-1 proteins |
05/09/2000 | US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle |
05/09/2000 | US6060327 Molecular wire injection sensors |
05/09/2000 | US6060326 Method to detect canine IgE and kit therefor |
05/09/2000 | US6060324 Bodipy 4,4,difluoro-3a,4a-diaza-s-indacene fluorophore in a liposomal solution. |
05/09/2000 | US6060323 Method and device for measuring blood coagulation or lysis by viscosity changes |
05/09/2000 | US6060322 Method for identification of reticulated cells |
05/09/2000 | US6060319 Temperature stabilized fluid reference system |
05/09/2000 | US6060311 Identifying a compound that inhibits retinoic acid suppression of ventricular muscle cell hypertrophy |
05/09/2000 | US6060303 Use in screening assays and as pharmaceuticals. |
05/09/2000 | US6060296 Protein kinases |
05/09/2000 | US6060295 Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases |
05/09/2000 | US6060294 Alanyl tRNA synthetase from Staphylococcus aureus |
05/09/2000 | US6060282 Streptococcus pneumoniae gene sequence Dpj |
05/09/2000 | US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
05/09/2000 | US6060275 Sprouty protein and coding sequence |
05/09/2000 | US6060260 Methods for reducing adsorption in an assay |
05/09/2000 | US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle |
05/09/2000 | US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
05/09/2000 | US6060255 Having 7s domain in its structure and recovered from collagen solution by pepsin digestion and repeated salt precipitation; for sensitive diagnosis and progression of liver fibrosis |
05/09/2000 | US6060254 Microcarrriers with molecules having affinity for viral envelope protein immobilized on surface; for rapid, direct, and sensitive detection of virus in serum; especially for hepatitis c and human immunodeficiency viruses |
05/09/2000 | US6060253 Monoclonal antibody which specificially inhibits catalyzed metabolism of bufuralol; used to screen drugs for their metabolism by 2d6 and/or identify 2d6 poor metabolizers by simple bioassays |
05/09/2000 | US6060252 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli |
05/09/2000 | US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
05/09/2000 | US6060244 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
05/09/2000 | US6060239 Cellubrevin homologs |
05/09/2000 | US6060237 Devices and methods for optical detection of nucleic acid hybridization |
05/09/2000 | US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
05/09/2000 | US6060064 Chimeric virus-like particle antigen presentation and delivery system |
05/09/2000 | US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite) |
05/09/2000 | US6060039 Insecticide resistance assay |
05/09/2000 | US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety |
05/09/2000 | US6060025 Catalytic gas detector with combustion sensor including pellistor having noble metal catalyst and coupled to combustion sensor a source of non-oxidizing hydrocarbon gas to regenerate poisoned catalyst, and controller |
05/09/2000 | US6060024 Automatic dissolution testing system |
05/09/2000 | US6060023 Molecular sensing apparatus |
05/09/2000 | US6059970 Membrane separation device |
05/09/2000 | US6059737 Adhesive gasket for blood collection needles |
05/09/2000 | US6059561 Compositions and methods for detecting and quantifying biological samples |
05/09/2000 | US6058947 Contamination monitoring system |
05/09/2000 | US6058934 Planar hematocrit sensor incorporating a seven-electrode conductivity measurement cell |
05/09/2000 | US6058763 Apparatus and method for automated biomonitoring of water quality |
05/09/2000 | US6058762 Sample preparation unit |
05/09/2000 | CA2189857C Method and means of quantifying the properties of paper |
05/09/2000 | CA2182371C Method for separating rare cells from a population of cells |
05/09/2000 | CA2107154C Sphagnum moss composition for the production of sheeted absorbent and method for evaluating the potential of sphagnum moss material for absorbing liquid |
05/09/2000 | CA2100586C Htlv-i and htlv-ii peptide antigens and methods |
05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
05/09/2000 | CA2004387C Cyclosporine binding protein and use in an assay for biologically-active cyclosporine |
05/09/2000 | CA2000545C Process and reagent for the determination of a specifically bindable substance |
05/06/2000 | CA2253093A1 Screening test for early detection of colorectal cancer |
05/04/2000 | WO2000025140A1 Method for determining platelet count |
05/04/2000 | WO2000025139A1 Luminescent protein stains containing transition metal complexes |
05/04/2000 | WO2000025138A2 Methods of diagnosing or prognosing alzheimer's disease |
05/04/2000 | WO2000025137A1 Assays for autoantibodies |
05/04/2000 | WO2000025136A1 Method for gold deposition |
05/04/2000 | WO2000025135A1 Dip-stick detection system |
05/04/2000 | WO2000025134A1 Assays for ligands for nuclear receptors |
05/04/2000 | WO2000025133A1 An apparatus for measuring opacity |
05/04/2000 | WO2000025132A1 Device and method for identification of fluid in a conduit |
05/04/2000 | WO2000025131A1 Determining meat quality of a live animal |
05/04/2000 | WO2000025130A1 Device for controlling the characteristics of a cooling liquid and method using same |
05/04/2000 | WO2000025127A1 Method of preparing delta-9-tetrahydrocannabinol |
05/04/2000 | WO2000025118A1 Quartz crystal microbalance with feedback loop for automatic gain control |
05/04/2000 | WO2000025116A1 Method and system for localizing discontinuities, especially inclusions of resin, in wood |
05/04/2000 | WO2000025113A1 Device for visualizing molecules |
05/04/2000 | WO2000025108A1 Method and apparatus for locating hidden corpses by detecting volatile gas combinations |
05/04/2000 | WO2000025106A2 Pharmacophore fingerprinting in qsar and primary library design |
05/04/2000 | WO2000025098A2 Capacitive measuring device |
05/04/2000 | WO2000024991A1 Spa chemistry monitor unit |
05/04/2000 | WO2000024940A1 Cellular arrays and methods of detecting and using genetic disorder markers |
05/04/2000 | WO2000024939A1 Complexity management and analysis of genomic dna |
05/04/2000 | WO2000024937A2 Parallel methods for genomic analysis |
05/04/2000 | WO2000024934A1 Phytomics: a genomic-based approach to herbal compositions |
05/04/2000 | WO2000024913A2 Mn gene and protein |
05/04/2000 | WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
05/04/2000 | WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
05/04/2000 | WO2000024889A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
05/04/2000 | WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
05/04/2000 | WO2000024886A1 Prv-1 gene and the use thereof |
05/04/2000 | WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
05/04/2000 | WO2000024875A1 Compositions and methods useful for treatment of depressive disorder based on an animal model |
05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
05/04/2000 | WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies |
05/04/2000 | WO2000024780A2 Compositions and methods for treating polycystic kidney disease |
05/04/2000 | WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
05/04/2000 | WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
05/04/2000 | WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
05/04/2000 | WO2000024753A1 Chromogenic substrates of sialidase and methods of making and using the same |
05/04/2000 | WO2000024751A1 Chelating agents for radioimmunotherapy |
05/04/2000 | WO2000024677A1 Materials for solid-state gas sensors |
05/04/2000 | WO2000024634A1 Systems and methods for modifying ice adhesion strength |
05/04/2000 | WO2000024417A1 A method of regulation |
05/04/2000 | WO2000024405A1 Compounds and their therapeutic use with diabetic complications |
05/04/2000 | WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway |